Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypothalamic-Pituitary-Adrenal Hypofunction in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) as a Consequence of Activated Immune-Inflammatory and Oxidative and Nitrosative Pathways
Gerwyn Morris, George Anderson, Michaël Maes
Molecular Neurobiology (2016) Vol. 54, Iss. 9, pp. 6806-6819
Closed Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Mateo Cortes Rivera, Claudio A. Mastronardi, Claudia Silva, et al.
Diagnostics (2019) Vol. 9, Iss. 3, pp. 91-91
Open Access | Times Cited: 229
Psycho-Neuroendocrine-Immune Interactions in COVID-19: Potential Impacts on Mental Health
Ícaro Raony, Camila Saggioro de Figueiredo, Pablo Pandolfo, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 181
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature
Anthony L. Komaroff, W. Ian Lipkin
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 173
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 143
Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses
Warren P. Tate, Max Walker, Eiren Sweetman, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 73
Chronic fatigue syndrome (CFS): Suggestions for a nutritional treatment in the therapeutic approach
Geir Bjørklund, Maryam Dadar, Joeri J. Pen, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 109, pp. 1000-1007
Open Access | Times Cited: 89
The clinical value of cytokines in chronic fatigue syndrome
Tiansong Yang, Yan Yang, Delong Wang, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 88
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
Stefan R. Bornstein, Karin Voit-Bak, Timo Donate, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 34-37
Open Access | Times Cited: 75
Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome
Manuel Ruiz-Pablos, Bruno Paiva, Rosario Montero-Mateo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis
AnnaLynn M. Williams, Carly Paterson Khan, Charles E. Heckler, et al.
Breast Cancer Research and Treatment (2021) Vol. 187, Iss. 1, pp. 275-285
Open Access | Times Cited: 60
Astragalus polysaccharide ameliorated complex factor-induced chronic fatigue syndrome by modulating the gut microbiota and metabolites in mice
Xin‐Tong Wei, Jiayun Xin, Wei Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114862-114862
Open Access | Times Cited: 35
Treatment of 95 post-Covid patients with SSRIs
Carla P. Rus, Bert E. K. de Vries, Ingmar E. J. de Vries, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
Hayley Arron, Benjamin D. Marsh, Douglas B. Kell, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives
Katharine A. Seton, José Espejo, Karen Giménez-Orenga, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 325-325
Open Access | Times Cited: 9
Cortisol level dysregulation and its prevalence—Is it nature's alarm clock?
Carol Jones, Christopher D. Gwenin
Physiological Reports (2020) Vol. 8, Iss. 24
Open Access | Times Cited: 63
Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations
Gerwyn Morris, Michael Berk, Michaël Maes, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5866-5890
Open Access | Times Cited: 62
Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?
Gerwyn Morris, Michaël Maes, Michael Berk, et al.
Metabolic Brain Disease (2019) Vol. 34, Iss. 2, pp. 385-415
Open Access | Times Cited: 58
Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination?
Varvara A. Ryabkova, Leonid P. Churilov, Yehuda Shoenfeld
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5164-5164
Open Access | Times Cited: 58
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
Peter L. Toogood, Daniel J. Clauw, Sameer Phadke, et al.
Pharmacological Research (2021) Vol. 165, pp. 105465-105465
Open Access | Times Cited: 51
Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology
George Anderson, Annalucia Carbone, Gianluigi Mazzoccoli
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1597-1597
Open Access | Times Cited: 47
Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration
Mahsa Dolatshahi, Mohammadmahdi Sabahi, Mohammad Hadi Aarabi
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2379-2394
Open Access | Times Cited: 45
Fatigue, Emotional Distress, and Illness Uncertainty in Patients with Metastatic Cancer: Results from the Prospective NEOETIC_SEOM Study
Adán Rodríguez‐González, Verónica Velasco-Durántez, Carla M. Martín-Abreu, et al.
Current Oncology (2022) Vol. 29, Iss. 12, pp. 9722-9732
Open Access | Times Cited: 37
Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID
Warren P. Tate, Max Walker, Katie Peppercorn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5124-5124
Open Access | Times Cited: 20
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?
Erifili Hatziagelaki, Maria Adamaki, Irene Tsilioni, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 367, Iss. 1, pp. 155-167
Open Access | Times Cited: 54
Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system
Romain K. Gherardi, Guillemette Crépeaux, François‐Jérôme Authier
Autoimmunity Reviews (2019) Vol. 18, Iss. 7, pp. 691-705
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top